+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Inhalable Drug Delivery Devices - Medical Devices Pipeline Product Landscape, 2021

  • PDF Icon

    Report

  • 156 Pages
  • December 2021
  • Region: Global
  • GlobalData
  • ID: 5521346
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher's Medical Devices sector report, “Inhalable Drug Delivery Devices - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Inhalable Drug Delivery Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Inhalable Drug Delivery device is meant to administer medications that are to be inhaled deeply into the lungs.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Inhalable Drug Delivery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Inhalable Drug Delivery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Inhalable Drug Delivery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Inhalable Drug Delivery Devices Overview
3 Products under Development
3.1 Inhalable Drug Delivery Devices - Pipeline Products by Stage of Development
3.2 Inhalable Drug Delivery Devices - Pipeline Products by Segment
3.3 Inhalable Drug Delivery Devices - Pipeline Products by Territory
3.4 Inhalable Drug Delivery Devices - Pipeline Products by Regulatory Path
3.5 Inhalable Drug Delivery Devices - Pipeline Products by Estimated Approval Date
3.6 Inhalable Drug Delivery Devices - Ongoing Clinical Trials
4 Inhalable Drug Delivery Devices - Pipeline Products under Development by Companies
4.1 Inhalable Drug Delivery Companies - Pipeline Products by Stage of Development
4.2 Inhalable Drug Delivery Devices - Pipeline Products by Stage of Development
5 Inhalable Drug Delivery Companies and Product Overview
5.1 Acorda Therapeutics Inc Company Overview
5.2 Actervis GmbH Company Overview
5.3 Aerami Therapeutics Inc Company Overview
5.4 Aerophase Inc Company Overview
5.5 Alexza Pharmaceuticals Inc Company Overview
5.6 Atossa Therapeutics Inc Company Overview
5.7 Baxter International Inc Company Overview
5.8 Bellerophon Therapeutics Inc Company Overview
5.9 Breath Therapeutics Holding BV Company Overview
5.10 California Northstate University College of Medicine Company Overview
5.11 Canigma A.L LTD Company Overview
5.12 Edixomed Ltd Company Overview
5.13 Engage Therapeutics Inc Company Overview
5.14 iDTx Systems, Inc. Company Overview
5.15 Impel NeuroPharma Inc Company Overview
5.16 Inhalation Sciences Sweden AB Company Overview
5.17 InhaleRx Ltd Company Overview
5.18 Invero Pharma LLC Company Overview
5.19 Jupiter Research LLC Company Overview
5.20 Kanabo Research Ltd Company Overview
5.21 Mallinckrodt Plc Company Overview
5.22 Medical Developments International Ltd Company Overview
5.23 Medspray BV Company Overview
5.24 Monash University Company Overview
5.25 Nemera La Verpilliere Company Overview
5.26 Next Safety, Inc. Company Overview
5.27 Nobilis Therapeutics Inc Company Overview
5.28 OncoSec Medical Inc Company Overview
5.29 Parnell Pharmaceuticals Inc Company Overview
5.30 Pharmosa Biopharm Inc Company Overview
5.31 Rhinomed Limited Company Overview
5.32 Rutgers Cancer Institute of New Jersey Company Overview
5.33 Sandoz International GmbH Company Overview
5.34 Seng Vital International GmbH Company Overview
5.35 Shenzhen Smoore Technology Ltd Company Overview
5.36 Technology Commercialization Partners LLC Company Overview
5.37 Tetra Bio-Pharma Inc Company Overview
5.38 Teva Pharmaceutical Industries Ltd Company Overview
5.39 Texas Tech University Health Sciences Center Company Overview
5.40 Third Pole Inc Company Overview
5.41 Tiziana Life Sciences PLC Company Overview
5.42 Torrent Pharmaceuticals Ltd Company Overview
5.43 University Hospital Southampton NHS Foundation Trust Company Overview
5.44 University of Texas Health Science Center at Houston Company Overview
5.45 Vectura Group Plc Company Overview
5.46 Veoli Ltd Company Overview
5.47 Vero Biotech LLC Company Overview
5.48 Via Therapeutics LLC Company Overview
5.49 Virpax Pharmaceuticals Inc Company Overview
5.50 VistaGen Therapeutics Inc Company Overview
5.51 VitalMIST Company Overview
5.52 Windtree Therapeutics Inc Company Overview
6 Inhalable Drug Delivery- Recent Developments
7 Appendix
7.1 Methodology
7.2 About The Publisher
7.3 Contact The Publisher
7.4 Disclaimer
  • Inhalable Drug Delivery Devices - Pipeline Products by Stage of Development
  • Inhalable Drug Delivery Devices - Pipeline Products by Segment
  • Inhalable Drug Delivery Devices - Pipeline Products by Territory
  • Inhalable Drug Delivery Devices - Pipeline Products by Regulatory Path
  • Inhalable Drug Delivery Devices - Pipeline Products by Estimated Approval Date
  • Inhalable Drug Delivery Devices - Ongoing Clinical Trials
  • Inhalable Drug Delivery Companies - Pipeline Products by Stage of Development
  • Inhalable Drug Delivery Devices - Pipeline Products by Stage of Development
  • Glossary

  • Inhalable Drug Delivery Devices - Pipeline Products by Stage of Development
  • Inhalable Drug Delivery Devices - Pipeline Products by Segment
  • Inhalable Drug Delivery Devices - Pipeline Products by Territory
  • Inhalable Drug Delivery Devices - Pipeline Products by Regulatory Path
  • Inhalable Drug Delivery Devices - Pipeline Products by Estimated Approval Date
  • Inhalable Drug Delivery Devices - Ongoing Clinical Trials

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Acorda Therapeutics Inc
  • Actervis GmbH
  • Aerami Therapeutics Inc
  • Aerophase Inc
  • Alexza Pharmaceuticals Inc
  • Atossa Therapeutics Inc
  • Baxter International Inc
  • Bellerophon Therapeutics Inc
  • Breath Therapeutics Holding BV
  • California Northstate University College of Medicine
  • Canigma A.L LTD
  • Edixomed Ltd
  • Engage Therapeutics Inc
  • iDTx Systems, Inc.
  • Impel NeuroPharma Inc
  • Inhalation Sciences Sweden AB
  • InhaleRx Ltd
  • Invero Pharma LLC
  • Jupiter Research LLC
  • Kanabo Research Ltd
  • Mallinckrodt Plc
  • Medical Developments International Ltd
  • Medspray BV
  • Monash University
  • Nemera La Verpilliere
  • Next Safety, Inc.
  • Nobilis Therapeutics Inc
  • OncoSec Medical Inc
  • Parnell Pharmaceuticals Inc
  • Pharmosa Biopharm Inc
  • Rhinomed Limited
  • Rutgers Cancer Institute of New Jersey
  • Sandoz International GmbH
  • Seng Vital International GmbH
  • Shenzhen Smoore Technology Ltd
  • Technology Commercialization Partners LLC
  • Tetra Bio-Pharma Inc
  • Teva Pharmaceutical Industries Ltd
  • Texas Tech University Health Sciences Center
  • Third Pole Inc
  • Tiziana Life Sciences PLC
  • Torrent Pharmaceuticals Ltd
  • University Hospital Southampton NHS Foundation Trust
  • University of Texas Health Science Center at Houston
  • Vectura Group Plc
  • Veoli Ltd
  • Vero Biotech LLC
  • Via Therapeutics LLC
  • Virpax Pharmaceuticals Inc
  • VistaGen Therapeutics Inc
  • VitalMIST
  • Windtree Therapeutics Inc